Protokol X Blog
Research navigation, verification literacy, systems education, and Open Brief Archive explainers for readers seeking clearer context.
Vendor Intelligence Index
Evidence-weighted vendor intelligence briefs ranked by documentation architecture, verification quality, transparency, and operational signal.
Selank vs Semax
A plain-language comparison of Selank and Semax, including their different research profiles, route evidence, and where the human evidence remains limited.
Lyophilized Peptide Reconstitution
A safety-first guide to what reconstitution means, the equipment commonly encountered, label-directed handling, storage boundaries, and when not to proceed.
Semax Research Brief
A Protokol X intelligence brief on BDNF findings, stroke-rehabilitation evidence, intranasal delivery, and the limits of the available research.
The Grey Market Isn't the Problem. Blind Trust Is.
The grey market is not the problem by itself. Entering it without a verification framework is. A Protokol X doctrine brief on COAs, vendor trust, blind trust, and structured verification.
GHK-Cu: Beyond the Surface
A Protokol X intelligence brief on copper peptide research, gene regulation, COPD, cognitive decline, and systemic longevity biology.
Retatrutide: The Triple-Agonist Architecture Brief
Understanding GLP-1, GIP, and glucagon signaling in a single molecule.
Tirzepatide: Understanding the First Dual Agonist
A Protokol X research brief examining how coordinated GLP-1 and GIP signaling established the first major dual-agonist metabolic architecture.
Semaglutide: Understanding the First Modern GLP-1 Agonist
A Protokol X intelligence brief examining how sustained GLP-1 receptor activation established the signaling architecture for later dual- and triple-agonist therapies.
Semaglutide: The Compound That Changed GLP-1 Research
A companion archive brief on the sustained GLP-1 agonist research that helped establish the foundation for later signaling architectures.
Single, Dual, and Triple Agonists
An operational brief explaining how receptor coverage expands from single to dual to triple agonists, and why signaling tier should come before compound evaluation.
The Triple G Foundation
Three signals. One architecture. A foundational systems brief examining GLP-1, GIP, and glucagon before compound-level evaluation.
Understanding Peptide Testing: Beyond the COA
A Protokol X educational brief explaining what peptide COAs can and cannot tell you, how verification layers work, and why continuity of evidence matters.
Understanding GLP Signaling
A foundation brief explaining GLP signaling, biological communication, metabolic pathways, and why systems thinking should come before product discussions.
CJC-1295 + Ipamorelin System Brief
An educational system brief explaining where CJC-1295 and Ipamorelin fit within growth hormone signaling, sleep, recovery, fasting, exercise, and IGF-1 research models.
The Protokol X Pillars Framework
Research architecture for Body, Mind, and Longevity inside the Protokol X ecosystem.
How to Use the Protokol X Calculator
Research arithmetic, documentation, and local-first record keeping within the Protokol X ecosystem.
The Protokol X Tracker
Documentation over memory. A Protokol X field guide for recording protocols, observations, reports, backups, and the information systems that support better decisions.
BPC-157
Research Brief
Mechanisms, verification signals, and regulatory context.
Why Lab Work Matters
A foundational Protokol X guide explaining why lab work matters for research navigation, baseline awareness, tracking, and reducing uncertainty through documentation.
How to Read a Peptide COA
Learn the core sections of a certificate of analysis, the difference between identity and purity signals, and the red flags that make documentation harder to trust.